SCARCE EXPOSURE TO SUNLIGHT
thus reducing Vitamin D synthesis.
plays an important role,
especially for menopausal women,
who often develop osteoporosis.
The main sources of Vitamin D
are fatty fish, egg yolk,
cod liver oil, and dairy products.
USE OF SOLAR CREAMS
High sun protection factors
limit the production
of Vitamin D.
As you become older,
there is a reduction in
Vitamin D production in the skin.
absorbs UV radiation
reducing the Vitamin D synthesis.
IBSA Vitamin D3 is available in two dosages to meet daily needs in different age groups and lifestyles.
You can take it anywhere, any time without water
Once placed in your mouth it melts in a few seconds
It leaves a pleasant orange taste
Orodispersible films (ODF) are increasingly gaining in popularity and represent a new concept in the administration of nutrient substances, without the need to drink water and making swallowing easier and safer for children and the elderly.
This innovative formulation consists of an ultra-thin strip (50-150 micron thick) of small size containing one or more suitable nutrients and excipients.
Once placed in the mouth, the film dissolves within seconds, providing the rapid bioavailability of the nutrients.
A variety of polymers are available for the preparation of ODFs, so that the formulation, once placed on the tongue or in the mouth, can dissolve rapidly in contact with saliva, ensuring a rapid local or systemic release.
IBSA uses food maltodextrins as polymers, a safe and established ingredient, at the base of the patented technology developed in the Group’s Italian plants.
IBSA Vitamin D3 is the first food supplement with the patented IBSA FilmTec® entirely developed by the Italian R&D Team.
The Research and Development activity is fundamental The Research and Development activity is fundamental for IBSA and focuses on the realization of innovative methodologies for the administration of nutrients, through the use of advanced technologies capable of making the administration of commonly used substances much easier and more effective, thus improving patient compliance. The orodispersible films (ODF), produced by IBSA Italia, represent the new frontier for the oral administration of various types of products.
IBSA currently employs more than 500 employees in Italy and has 65 patents on cutting-edge pharmaceutical technologies.
The products developed and manufactured in Italy are sold in more than 80 countries around the world.